Iomai Corp.'s Phase I flop with its influenza-vaccine patch knocked shares down 40 percent, and sent researchers back to the drawing board - armed, at least, with data that their adjuvant to the vaccine, called LT, helped response. (BioWorld Today)

BioWorld's offices are closed today Monday, May 28, in observance of the Memorial Day holiday in the U.S. No issue was published.